Stock Events

Stock Events

Kymera Therapeutics (KYMR) Q4 2024 Earnings

31OctConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.83

-0.64

-0.44

-0.25

Details

Expected EPS

-0.832283

Actual EPS

-0.82

Surprise EPS

0.01

Surprise Percent

+1.48%

Description

Kymera Therapeutics (KYMR) has reported earnings of -0.82 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.